Press release
Skeletal Disease Drug Development Pipeline Review, 2017
Skeletal Disease Drug Development Pipeline Review, 2017
Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications.
Postmenopausal osteoporosis is the most common subtype of osteoporosis, and affects many women after menopause. Signs and symptoms of osteoporosis include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, a bone fracture that occurs much more easily than expected. Prevention and treatment include calcium and vitamin D, exercise, and other osteoporosis medications.
The size of these pipelines ranges from 13 products in postmenopausal osteoporosis to 116 in OA. The predominant targets within OA are prostaglandin G/H synthases 1 and 2, although a wide range of targets, including extracellular matrix-organizing proteins and interleukins, are being studied. Likewise, within both osteoporosis and the post-menopausal subtype, a broad range of molecular targets are being studied. The targets being most frequently studied are the parathyroid hormone receptor, tumor necrosis factor ligand superfamily member 11 and sclerostin.
Scope
- Which companies are the most active within the pipeline for osteoporosis and OA therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of osteoporosis and OA therapeutics?
To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41492
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/skeletal-disease-drug-development-pipeline-review-2017
About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston,
MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Skeletal Disease Drug Development Pipeline Review, 2017 here
News-ID: 783802 • Views: …
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence…
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports.
Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors.
Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that…
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports.
This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers:
• CommScope/Airvana
• Comba Telecom
• Ericsson
• Huawei Technologies
• Nokia
• SpiderCloud
• ZTE Corporation
This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021.
To view a detailed description and Table of…
More Releases for Skeletal
Skeletal Dysplasia Market Size & Analysis - Forecast to 2026
As per the research conducted by GME, the Skeletal Dysplasia Market will grow with a CAGR value of 3.8 percent. The global skeletal dysplasia market is being driven by increased understanding and timely detection of skeletal dysplasia. Another aspect that is likely to boost the global market in the forecast period is technological advances Furthermore, the occurrence of skeletal dysplasia in young kids is rising. These variables are envisioned to…
Skeletal Dysplasia Market Size - Forecasts to 2026
As per the research conducted by GME, the Global Skeletal Dysplasia Market will grow with a CAGR value of 4.5% by 2026. The factors driving the skeletal dysplasia market are as follows: Rising cases of birth defects, out of every 5000 newborn babies there is 1 baby born with skeletal dysplasia. Advancement in medical science due to which quite of several treatments are now available for the cure of skeletal…
Mango Animate Provides a Free Skeletal Animation Maker
Mango Animate’s new skeletal animation maker will empower every user to create a stunning skeletal animation.
Mango Animate’s skeletal animation(https://school.mangoanimate.com/free-skeletal-animation-make-bone-animation-in-3-minutes/) maker contains a large number of animated characters. And most users can find a pre-made character representing their jobs and all the characters are boned so users can easily rig them. Meanwhile, this software also has a huge motion library that includes facial expressions and body movements such as blinking, walking,…
Skeletal Dysplasia Market Surge Towards Solid Growth by 2027
Zion Market Research, A leading market research firm added a research report on "Skeletal Dysplasia Market: by Type (X-linked Hypophosphatemia, Hypophosphatasia, Achondroplasia, Fibrodysplasia Ossificans Progressive, Multiple Osteochondromas, and Others), and by Treatment (Medication, Surgery, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025" to its research database. This Skeletal Dysplasia Market report analyzes the comprehensive overview of the market comprising an executive summary that covers core trends…
Skeletal Disease Drug Development Pipeline Review, 2017
Report Hive Market Research Released a New Research Report of 176 pages on Title " Skeletal Disease Drug Development Pipeline Review, 2017 "with detailed Analysis, Forecast and Strategies.
Skeletal Disease Drug Development Pipeline Review, 2017
Summary
This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for osteoporosis, post-menopausal osteoporosis and osteoarthritis (OA).
OA is one…
Growing Demand for Skeletal Disease Drug Development Pipeline Review, 2017
"The Report Skeletal Disease Drug Development Pipeline Review, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for osteoporosis, post-menopausal osteoporosis and osteoarthritis (OA).
OA is one of the most common forms of arthritis. It…
